<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> represents a major <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, few studies have addressed the impact of the disease duration on mortality </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, we aimed to investigate the predictive value of <z:mp ids='MP_0002055'>diabetes</z:mp> duration for <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality in subjects undergoing coronary angiography </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied 2455 participants of the LUdwigshafen RIsk and Cardiovascular health study (1768 males/687 females) </plain></SENT>
<SENT sid="4" pm="."><plain>They had a mean ± standard deviation (SD) age of 63.1 ± 9.0 years (range: 40.0-79.9) and a mean ± SD body mass index of 27.7 ± 4.0 kg/m(2) </plain></SENT>
<SENT sid="5" pm="."><plain>704 subjects were newly diagnosed with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> according to the 2010 criteria of the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association and 446 subjects had a known history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The mean ± SD duration of the follow-up for <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality was 7.4 ± 2.3 years </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: A total of 543 <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred during the follow-up </plain></SENT>
<SENT sid="8" pm="."><plain>Among these, 343 were accounted for by <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The duration of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was strongly and positively correlated with <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality (both P&lt;0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>The multivariate adjusted hazard ratios (95% confidence intervals) for cardiovascular mortality compared to subjects without <z:mp ids='MP_0002055'>diabetes</z:mp> were 1.76 (1.34-2.32), 2.86 (2.00-4.08), 2.96 (1.85-4.74), and 4.55 (3.24-6.39) for subjects with new <z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and subjects with known type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (duration ≤ 5, &gt;5 and ≤ 10, &gt;10 years), respectively </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The data emphasise the need to consider the <z:mp ids='MP_0002055'>diabetes</z:mp> duration for the prediction of mortality in subjects at intermediate to high cardiovascular risk </plain></SENT>
</text></document>